Close Window

Digital Look Email A Friend

Hikma lifts FY generics guidance as first-half profits, revenue jump

Published by Michele Maatouk on 6th August 2021

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

URL: http://www.digitallook.com/dl/news/story/32040080/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.